Spinale Metastasen stellen eine häufige Ursache für
eine deutlich eingeschränkte Lebensqualität bei
Pat. mit metastasierenden Tumoren dar. Die Behandlung erfolgt interdisziplinär
abhängig vom klinischen Zustand des Patienten. Die Rolle der
Chirurgie in der Therapie variiert erheblich je nach Literaturquelle,
von keiner Bedeutung bis hin zur Empfehlung der radikalen chirurgischen Resektion.
Die Behandlung spinaler Metastasen ist in ein interdisziplinäres
Konzept einzubinden bei dem neben dem Onkologen und dem Radioonkologen
auch der Wirbelsäulenchirurg eine entscheidende Rolle spielt.
Die Behandlung sollte immer eine Individualentscheidung darstellen,
wobei die Therapie die Beherrschung der Schmerzen, die Verhinderung
neurologischer Defizite und damit die Verbesserung der Lebensqualität
sowie ggf. eine langfristige Tumorkontrolle zum Ziel haben sollte.
Abstract
Spinal metastases represent a significant cause of morbidity
in patients diagnosed with malignancies. The treatment paradigm
involves a cohesive multidisciplinary approach that allows treatment
plans to be made in the context of a patient‘ overall condition.
Opinions vary widely as to the role of surgery, from none to wide
margin excision. The treatment should be taylor made for the individual.
The primary aim of any treatment is the improvement of the quality
of life by treatment of pain and avoidance of new neurological deficits.
In individual cases a long lasting tumor control can be achieved.
1
Bartels R HMA, van der Linden Y M, van der Graaf W TA.
Spinal
extradural metastasis: review of current treatment options.
CA:
a cancer journal for clinicians.
2008;
58
245-259
4
Chen Y J, Chang G C, Chen W H. et al .
Local metastases along the
tract of needle: a rare complication of vertebroplasty in treating
spinal metastases.
Spine.
2007;
32
E615-618
6
Gasbarrini A, Li H, Cappuccio M. et al .
Efficacy Evaluation of a New Treatment
Algorithm for Spinal Metastases.
Spine (Phila Pa 1976).
2010;
DOI: 10.1097/BRS.0b013e3181c680b9
8
Harrington K D.
Anterior cord decompression and spinal stabilization for patients
with metastatic lesions of the spine.
J Neurosurg.
1984;
61
107-117
9
Hosono N, Ueda T, Tamura D. et
al .
Prognostic relevance of clinical symptoms in patients
with spinal metastases.
Clin Orthop Relat Res.
2005;
436
196-201
10
Ibrahim A, Crockard A, Antonietti P. et al .
Does spinal surgery improve the quality
of life for those with extradural (spinal) osseous metastases? An
international multicenter prospective observational study of 223
patients. Invited submission from the Joint Section Meeting on Disorders
of the Spine and Peripheral Nerves, March 2007.
Journal
of neurosurgery Spine.
2008;
8
271-278
14
North R B, LaRocca V R, Schwartz J. et al .
Surgical management of spinal metastases:
analysis of prognostic factors during a 10-year experience.
Journal
of neurosurgery Spine.
2005;
2
564-573
15
Patchell R A, Tibbs P A, Regine W F. et al .
Direct decompressive surgical resection
in the treatment of spinal cord compression caused by metastatic
cancer: a randomised trial.
Lancet.
2005;
366
643-648
17
Polascik T J.
Bisphosphonates in oncology: evidence for the prevention of
skeletal events in patients with bone metastases.
Drug
Des Devel Ther.
2009;
3
27-40
21
Tokuhashi Y, Ajiro Y, Umezawa N.
Outcome of treatment for spinal metastases using scoring system
for preoperative evaluation of prognosis.
Spine.
2009;
34
69-73
22
Tokuhashi Y, Matsuzaki H, Oda H. et al .
A revised scoring system for preoperative
evaluation of metastatic spine tumor prognosis.
Spine.
2005;
30
2186-2191
23
Tokuhashi Y, Matsuzaki H, Toriyama S. et al .
Scoring system for the preoperative evaluation
of metastatic spine tumor prognosis.
Spine.
1990;
15
1110-1113
25
van der Linden Y M, Dijkstra S P, Vonk E J. et al .
Prediction of
survival in patients with metastases in the spinal column: results
based on a randomized trial of radiotherapy.
Cancer.
2005;
103
320-328
26
Yamashita T, Siemionow K B, Mroz T E. et al .
A prospective analysis of prognostic
factors in patients with spinal metastases: use of the revised tokuhashi
score.
Spine (Phila Pa 1976).
2011;
36
910-917
27
Yuen K K, Shelley M, Sze W M. et al .
Bisphosphonates for advanced prostate cancer.
Cochrane Database Syst Rev.
2006;
CD006250
DOI: 10.1002/14 651 858.CD006250